Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease

被引：0
作者：
Phuc N. H. Trinh
Jo-Anne Baltos
Shane D. Hellyer
Lauren T. May
Karen J. Gregory
机构：
[1] Monash University,Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences
[2] Monash University,Department of Pharmacology
[3] Monash Institute of Pharmaceutical Sciences,ARC Centre for Cryo
来源：
Purinergic Signalling | 2022年 / 18卷 / 4期
关键词：
D O I：
10.1007/s11302-022-09906-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：407 / 407
相关论文
共 50 条
  • [21] Astroglial calcium signalling in Alzheimer's disease
    Verkhratsky, Alexei
    Rodriguez-Arellano, J. J.
    Parpura, Vladimir
    Zorec, Robert
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (04) : 1005 - 1012
  • [22] Mitochondrial oxidant signalling in Alzheimer's disease
    Vina, Jose
    Lloret, Ana
    Valles, Soraya L.
    Borras, Consuelo
    Badia, Mari-Carmen
    Pallardo, Federico V.
    Sastre, Juan
    Alonso, Maria-Dolores
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (02) : 175 - 181
  • [23] Oxidative stress signalling in Alzheimer's disease
    Zhu, XW
    Raina, AK
    Lee, HG
    Casadesus, G
    Smith, MA
    Perry, G
    BRAIN RESEARCH, 2004, 1000 (1-2) : 32 - 39
  • [24] Chaperone signalling complexes in Alzheimer's disease
    Koren, John, III
    Jinwal, Umesh K.
    Lee, Daniel C.
    Jones, Jeffrey R.
    Shults, Cody L.
    Johnson, Amelia G.
    Anderson, Laura J.
    Dickey, Chad A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (04) : 619 - 630
  • [25] Intracellular calcium signalling in Alzheimer's disease
    Hermes, Marina
    Eichhoff, Gerhard
    Garaschuk, Olga
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (1-2) : 30 - 41
  • [26] Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target?
    Merighi, Stefania
    Travagli, Alessia
    Nigro, Manuela
    Pasquini, Silvia
    Cappello, Martina
    Contri, Chiara
    Varani, Katia
    Vincenzi, Fabrizio
    Borea, Pier Andrea
    Gessi, Stefania
    BIOMOLECULES, 2023, 13 (06)
  • [27] Amyloid and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A() receptor
    Liu, Zhenhua
    Wang, Fumin
    Tang, Minglu
    Zhao, Yongjun
    Wang, Xiaoting
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (01) : 435 - 442
  • [28] Publisher Correction to: Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
    Jinhua Wen
    Menghua Zhao
    Wenxiong Sun
    Xiaohua Cheng
    Luyi Yu
    Duanwen Cao
    Pu Li
    BMC Neuroscience, 22
  • [29] Publisher Correction: The adenosine pathway in immuno-oncology
    Bertrand Allard
    David Allard
    Laurence Buisseret
    John Stagg
    Nature Reviews Clinical Oncology, 2020, 17 (10) : 650 - 650
  • [30] An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment?
    Merighi, Stefania
    Poloni, Tino Emanuele
    Pelloni, Lucia
    Pasquini, Silvia
    Varani, Katia
    Vincenzi, Fabrizio
    Borea, Pier Andrea
    Gessi, Stefania
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345